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Themechanistic target of rapamycin complex 1 (mTORC1) is
a master regulator of protein synthesis and potential target for
modifying cellular metabolism in various conditions, including
cancer and aging. mTORC1 activity is tightly regulated by the
availability of extracellular amino acids, and previous studies
have revealed that amino acids in the extracellular fluid are
transported to the lysosomal lumen. There, amino acids induce
recruitment of cytoplasmicmTORC1 to the lysosomeby theRag
GTPases, followed by mTORC1 activation by the small GTPase
Ras homolog enriched in brain (Rheb). However, how the extra-
cellular amino acids reach the lysosomal lumen and activate
mTORC1 remains unclear. Here, we show that amino acid
uptake by dynamin-dependent endocytosis plays a critical role
in mTORC1 activation. We found that mTORC1 is inactivated
when endocytosis is inhibited by overexpression of a dominant-
negative form of dynamin 2 or by pharmacological inhibition of
dynamin or clathrin. Consistently, the recruitment of mTORC1
to the lysosome was suppressed by the dynamin inhibition. The
activity and lysosomal recruitment ofmTORC1were rescued by
increasing intracellular amino acids via cycloheximide exposure
or by Rag overexpression, indicating that amino acid depriva-
tion is the main cause of mTORC1 inactivation via the dynamin
inhibition. We further show that endocytosis inhibition does
not induce autophagy even though mTORC1 inactivation is
known to strongly induce autophagy. These findings open new
perspectives for the use of endocytosis inhibitors as potential
agents that can effectively inhibit nutrient utilization and shut
down the upstream signals that activate mTORC1.
Animals store energy when abundant nutrients are available
in the bloodstream. Inversely, when nutrients are limited, cat-
abolic breakdown of stored materials is triggered to provide
energy and building blocks that support survival in the starved
condition (1). The regulation of nutrient storage and consump-
tion is governed by a kinase called mechanistic target of rapa-
mycin (mTOR),3 which is evolutionally conserved from yeast to
human. The activity of mTOR is regulated by nutrients, growth
factors, and cellular stresses. ActivatedmTOR strongly induces
a net anabolic effect by up-regulating anabolic pathways and
down-regulating the catabolic autophagy pathway at the same
time (1).
The mTOR protein is a catalytic subunit and forms two
distinct complexes, mTOR complex 1 and 2 (mTORC1 and
mTORC2, respectively), based on differences in its subunit
composition. The mTORC1 complex has been shown to play
an important role in protein synthesis. The substrates of
mTORC1 include S6 kinase 1 (S6K1) and eIF4E-binding pro-
tein 1 (4E-BP1), both of which enhance mRNA translation
when phosphorylated by mTORC1 (2). In addition to promot-
ing protein synthesis, mTORC1 suppresses autophagy likely
through the phosphorylation of Atg13 and ULK1 (3). Because
a net increase in protein mass, which is accomplished by
mTORC1, primes cells for growth and proliferation, it is spec-
ulated that unregulated activation of mTORC1 is associated
with cancer proliferation. This speculation is supported by the
fact that loss-of-function mutations of negative regulators of
mTORC1, such as TSC1-TSC2, PTEN, and LKB1, are fre-
quently found in cancers (2). Moreover, previous studies have
also shown that life longevity can be increased by suppressing
mTORC1 via moderate starvation and dietary restriction (4).
Therefore, suppression of mTORC1 activity may be a reasona-
ble approach against cancer and aging.
In previous studies, extracellular amino acids have been
identified as a strong stimulator of mTORC1 activation (5, 6),
but the mechanism of how extracellular amino acids induces
mTORC1 remained unknown. However, recent studies have
revealed that amino acids inside the lysosome are the key to
mTORC1 activation, and the vacuolar-type H-ATPase
(V-ATPase) and the amino acid transporter SLC38A9 in the
lysosomal membrane have been identified to be sensors for
intra-lysosomal amino acids (7, 28). When these sensors detect
amino acids, they activate the Rag GTPases through the gua-
nine-nucleotide exchange factor activity of Ragulator, which is
a protein complex that tethers the Rag GTPases to the lyso-
somal membrane (8, 9).When activated, the Rag GTPases bind
to the mTORC1-specific subunit Raptor, recruiting mTORC1
from the cytoplasm to the lysosomal membrane (10). In addi-
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tion, a mechanism of mTORC1 recruitment that is V-ATPase-
dependent but Rag-independent has been reported. In this
case, ADP-ribosylation factor 1 (Arf1) plays a role in mTORC1
activation (11). The recruitment of mTORC1 to the lysosome
allows for its activation by Rheb, which is specifically localized
on endomembranes, including the lysosomal membrane.
Although the activity of Rheb is enhanced by growth factors
through pathways that involve PI3K, mTORC2, Akt, and
TSC1–2 (2), amino acids are prerequisites formTORC1 activa-
tion (6). Consistent with the importance of lysosomes for
mTORC1 activation, the disturbance of intracellular mem-
brane traffic by overexpressing Rab mutants abrogates amino
acid-induced mTORC1 activation (12–14).
Strikingly, cell-free experiments with isolated lysosomes and
the purifiedmTORC1-specific subunit Raptor have shown that
amino acid-induced Raptor recruitment can occur on isolated
lysosomes, suggesting that all the necessary components,
including the amino acid sensors and scaffold proteins, exist in
the lysosome (7). Moreover, membrane-permeable alcohol-es-
ter amino acids are more potent to induce the recruitment of
Raptor in this cell-free system. In contrast, artificial depletion of
amino acids from the lysosomal lumen resulted in the abroga-
tion of Raptor recruitment (7), suggesting that the amino acids
are sensed on the luminal side of the lysosome.
The existence of the amino acid sensors within the lysosomal
lumen raises the fundamental question of how extracellular
amino acids are transported into the lysosomal lumen. Because
the permeability of amino acids through the lipid bilayers is
very low (15), mechanisms must exist for the cell to effectively
transport extracellular amino acids into the lysosomal lumen.
Recent studies have suggested that macropinocytosis is re-
quired for mTORC1 activation (16, 17). Macropinocytosis is
a specific form of endocytosis that is induced by growth factors
or oncogenic mutations (18). When macropinocytosis is
induced, membrane ruffling and subsequent membrane clo-
sure result in the incorporation of a relatively large amount of
extracellular fluid. It has been shown that growth factor-in-
duced macropinocytosis is required for the induction of
mTORC1 activation 5–15 min after stimulating serum-starved
cells with growth factors (17). On the other hand, another
group has shown that, in the absence of essential amino acids,
cells harboring the K-Ras G12D mutation required macropi-
nocytosis of extracellular proteins for the maintenance of
mTORC1 activity (16). In their study, however, they show that
macropinocytosis is not required for mTORC1 activation if
extracellular amino acids are present, which suggests the exist-
ence of amacropinocytosis-independentmechanism for amino
acid uptake.
One possible mechanism involves amino acid transporters
(19). For example, mTORC1 is regulated by cellular uptake of
glutamine by the glutamine transporter SLC1A5 and by the
subsequent exchange of intracellular glutamine with extracel-
lular essential amino acids by the bidirectional transporter
SLC7A5/SLC3A2 (20). However, more general forms of endo-
cytosis, such as clathrin- and caveolae-mediated endocytosis,
may play a role in the effective transport of amino acids from
the extracellular space to the lysosome. In contrast to macropi-
nocytosis, which utilizes membrane ruffling, these forms of
endocytosis utilize invagination on the plasma membrane and
the subsequent formation of endocytic vesicles. Both clathrin-
and caveolae-mediated endocytosis are dependent ondynamin,
a GTPase that helps pinch off the endocytic vesicles (21).
In this study, we examined the significance of dynamin-de-
pendent endocytosis for mTORC1 activity in the presence of
extracellular amino acids, and found that dynamin-dependent
endocytosis of amino acids is required for the induction and
maintenance of mTORC1 activity. Importantly, inhibition of
endocytosis suppresses two compensatory reactions normally
induced by mTORC1 inactivation: enhanced nutrient genera-
tion by endocytosis and by autophagy, thereby providing a
more thorough method for the cell to inhibit nutrient utiliza-
tion. Thus, inhibition of endocytosis-mediated nutrient uptake
may be a reasonable approach to mTORC1- and nutrient-de-
pendent conditions such as cancer and aging.
Results
Endocytosis inhibition results inmTORC1 inactivation
Recent studies have revealed that mTORC1 is activated
when amino acids in the lysosomal lumen are sensed by the
V-ATPase (7) and by SLC38A9 (28). We suspected that, in the
presence of extracellular amino acids, dynamin-dependent
endocytosis of amino acids may be critical for the maintenance
of mTORC1 activity. To test this, we examined the effect of
overexpressing a dominant-negative form of dynamin 2
(dynamin 2 K44A). Although dynamin 2 exhibits ubiquitous
expression, dynamin 1 is specific to neurons and dynamin 3 is
predominantly expressed in the testis, lung, and neurons (21).
Weoverexpressed dynamin 2K44A in 293T cells, a cell line that
has beenwidely used andwell-characterized in studies of amino
acid-dependent mTORC1 activation (7–10). As shown in Fig.
1A, the overexpression of dynamin 2 K44A effectively reduced
mTORC1 activity as assessed by the decreased phosphorylation
of S6KatThr389, suggesting that dynamin-dependent processes
are required for mTORC1 activation. In contrast, no apparent
changes were observed in the phosphorylation of Akt at Thr308
and Ser473, both of which would enhance Akt activity (Fig. 1A)
(22), indicating that the decreased mTORC1 activity by
dynamin inhibition was not likely the result of the decreased
activity of the upstream kinase Akt. We also confirmed that
expression levels ofmTORC1 subunitsmTORandRaptorwere
not affected by dynamin inhibition (supplemental Fig. S1). This
suggests that the decreased mTORC1 activity was not caused
by the change in protein levels of these mTORC1 subunits.
After confirming the effect of the dynamin 2 K44A overex-
pression, we next tested the pharmacological inhibition of
dynamin by Dynasore (23). As shown in Fig. 1C, we observed
rapid inactivation of mTORC1 shortly after the addition of
Dynasore. The mTORC1-suppressing effect was obvious as
early as 15 min after the addition of Dynasore. Similarly, the
clathrin inhibitor PitStop 2 (24) resulted in the inhibition of
mTORC1 activity, showing that two different inhibitors of
endocytosis can lead to mTORC1 inactivation. Suppression
of endocytosis by Dynasore and PitStop 2 was confirmed by
microscopic observations of DQTM BSA, a protease substrate
that becomes fluorescent when endocytosed and subsequently
mTORC1 activation by amino acid endocytosis























hydrolyzed in the lysosome (supplemental Fig. S2). Therefore,
the pharmacological inhibition of dynamin-dependent endocy-
tosis results in rapid and sustained inactivation of mTORC1
activity.
Endocytosis inhibitors and amino acid deprivation lead to
inactivation ofmTORC1 but notmTORC2
In contrast to endocytosis inhibitors that specifically inacti-
vate mTORC1, the dual mTOR inhibitor Torin 1, which inhib-
its mTORC1 andmTORC2 (25), induces dephosphorylation of
Akt and S6K (Fig. 2).On the other hand, amino acid deprivation
resulted in mTORC1 inactivation but did not affect the phos-
phorylation of Akt. Both of these observations were similar to
what was observed when endocytosis was inhibited (Fig. 2).
This suggests the possibility that mTORC1 inactivation by
endocytosis inhibition may be the result of decreased cellular
uptake of extracellular amino acids.
Endocytosis inhibitors prevent activation and lysosomal
localization ofmTORC1 induced by amino acid stimulation
Previous studies have shown that mTORC1 inactivated by
amino acid deprivation is rapidly reactivated by amino acid
stimulation (6, 10). Consistent with these studies, mTORC1
was inactivated by incubating the cells in amino acid-free
mediumcontaining dialyzed serum for 50min, and reactivation
of mTORC1 was observed at 10 or 40 min after the reintroduc-
tion of amino acids (Fig. 3, A and B); however, reactivation of
mTORC1was effectively suppressed byDynasore and PitStop 2
(Fig. 3, A and B).
It has been shown that amino acid deprivation from the
medium causes detachment of mTORC1 from the lysosome (7,
10). If the endocytosis of extracellular amino acids is required
for mTORC1 activation, dynamin inhibition should result in
the detachment of mTORC1 from the lysosome as observed in
amino acid-deprived cells. To test this, we performed immuno-
fluorescence for mTOR and the lysosomal marker Lamp1 and
quantified the fluorescence images by two different methods
(counting cells that exhibit mTOR-Lamp1 colocalization and
quantifying fluorescence intensity of mTOR in Lamp1-positive
areas) (Fig. 3, C–E). As previously reported (10), we confirmed
that amino acid deprivation for 50 min caused diffusive mTOR
localization throughout the cytoplasm in 293T cells, and the
subsequent reintroduction of amino acids for 40 min rescues
the accumulation of mTOR on the lysosome (Fig. 3,C–E). This
amino acid-dependent relocalization of mTOR was effectively
prevented byDynasore (Fig. 3,C–E). Taken together, these data
suggest that endocytosis inhibition prevents the amino acid-de-
pendent recruitment of mTORC1 to the lysosome and subse-
quent mTORC1 activation, likely by inhibiting amino acid
endocytosis.
Lysosomal localization and activation ofmTORC1 are
prevented by endocytosis inhibition and rescued by
cycloheximide (CHX)
Similarly to amino acid deprivation, treatment of cells with
Dynasore for 1 h resulted in the detachment ofmTOR from the
lysosome even in the presence of extracellular amino acids (Fig.
4, A–C). Moreover, this detachment of mTOR from the lyso-
somebyDynasorewas reversed by the simultaneous addition of
CHX, which inhibits protein synthesis and elevates intracellu-
lar amino acid levels (7) (Fig. 4, A–C). Consistently, Western
blot analysis of phospho-S6K showed that CHX reversed the
inactivation of mTORC1 by Dynasore (Fig. 4, D and E). These
results suggest that the mTORC1 inactivation caused by endo-
Figure1. Endocytosis inhibition results inmTORC1 inactivation.A,293Tcellswere transfectedwithpcDNA3.1 vector (mock) orpcDNA3.1/dynamin2K44A.
Cellswereharvestedat 24hafter transfection.B,quantificationof the immunoblot data inA. Eachbar indicatesmeanS.D. of three independent experiments.
*, p 0.05. C, 293T cells were treated with 0.1% DMSO (vehicle), 80 M Dynasore, or 30 M PitStop 2 for the indicated time.
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cytosis inhibition ismediated by a failure to uptake extracellular
amino acids.
mTORC1 inactivation by endocytosis inhibition is rescued by
overexpression of Rag GTPases and Rheb
As described above, activation ofmTORC1 by amino acids is
regulated by the Rag GTPases and Rheb. The Rag GTPases are
localized on the lysosome and activated in the presence of
amino acids. Upon activation, the Rag GTPases bind to
mTORC1 and recruits it to the lysosome, where mTORC1 is
activated by Rheb. Therefore, if endocytosis inhibition causes
mTORC1 inactivation via these amino acid-dependent pro-
cesses, overexpression of Rheb or constitutively active Rag
should rescue the decreased activity of mTORC1 in endocyto-
sis-inhibited cells. To test this, we simultaneously overex-
pressed the constitutively active forms of RagB and RagC
(RagBGTP and RagCGDP) or singly overexpressed Rheb. Over-
expression of these proteins is known to bypass the require-
ment of amino acids for mTORC1 activation (7, 10). As shown
in Fig. 5, mock transfection did not rescue the decreased
mTORC1 activity caused by Dynasore. In contrast, both
RagBGTP/RagCGDP and Rheb partly rescued the decreased
mTORC1 activity. Although this tendency for rescue was con-
sistently observed in all three experiments, the rescue was only
partial, especially for RagBGTP/RagCGDP overexpression. This
may be because the transfection efficiency and expression levels
were not sufficiently high (Fig. 5A). Indeed, transfection effi-
ciency was estimated to be around 37% for RagBGTP/RagCGDP
and 44% for Rheb, when analyzed by flow cytometry (supple-
mental Fig. S3), causing an underestimation of the effect of the
Rag/Rheb overexpression. Nevertheless, when transfected
cells were individually observed by fluorescence microscopy,
RagBGTP/RagCGDP rescued the decreased lysosomal localiza-
tion of mTOR caused by Dynasore in most of the transfected
cells (Fig. 5, C andD), suggesting that lysosomal recruitment of
mTORC1 can be bypassed by constitutively active Rag.
Endocytosis inhibition leads to decreased autophagic activity
evenwithmTORC1 inactivation
Wenext tested ifmTORC1 inactivation byDynasore induces
autophagy, an intracellular degradation system. Autophagy is
suppressed by mTORC1, and therefore autophagic activity is
maintained at a low level in the presence of amino acids and
growth factors. Inversely, pharmacological inhibition of
mTORC1 and amino acid deprivation are known to strongly
induce autophagy (3). Therefore, it is possible that inhibition of
endocytosis induces autophagy as a consequence of mTORC1
inactivation. To assess autophagic activity in endocytosis-in-
hibited cells, Western blot analysis of LC3 with the lysosomal
inhibitor bafilomycin A1 (Baf A1) was performed (Fig. 6). We
found that LC3-II turnover (calculated as the difference in
LC3-II amount when the cells were treated with and without
Baf A1 as described under “Experimental procedures”), which
reflects autophagic activity, markedly decreased in Dynasore-
and PitStop 2-treated cells under both the resting and
autophagy-inducing conditions (Torin 1 and amino acid star-
vation) (Fig. 6). Consistent with this, microscopic observation
revealed that Dynasore and PitStop 2 suppressed the formation
of dot-like structures of LC3 (isolation membranes and
autophagosomes) and WIPI2 (autophagosome formation sites
and isolation membranes) (3). These results indicate that
autophagy was suppressed by the endocytosis inhibitors.
Although this result seems inconsistent with the model that
mTORC1 inactivation leads to the induction of autophagy, it
is still consistent with previous studies that suggest endo-
cytic membranes contribute to the progression of autophagy
(26, 27).
Discussion
In this study, we found that dynamin-dependent endocytosis
is required for mTORC1 activation after it is recruited to the
lysosome. It is likely that, in a steady-state conditionwith extra-
cellular amino acids, dynamin-dependent endocytosis main-
tains mTORC1 activity by constitutively transporting extra-
cellular amino acids to the lysosomal lumen. This model is
supported bymultiple experiments that include overexpression
of a dominant-negative form of dynamin and the treatment
with two different endocytosis inhibitors (Dynasore and Pit-
Figure2. Endocytosis inhibitors andaminoaciddeprivation lead to inac-
tivation ofmTORC1 but notmTORC2. A, 293T cells were treated for 1 or 4 h
with 0.1% DMSO, 80 M Dynasore, 30 M PitStop 2, or 250 nM Torin 1 in
RPMI1640 medium containing 10% Nu-Serum, or with amino acid- and
serum-free RPMI1640 medium. B, quantification of immunoblot data in A.
Eachbar indicatesmeanS.D. of three independent experiments. *,p0.05;
***, p 0.001; ****, p 0.0001 compared with the vehicle treatment group.
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Stop 2). Endocytosis inhibition also prevented mTORC1 reac-
tivation induced by amino acid stimulation, suggesting that
endocytosis is required for a quick response to sudden increases
in extracellular amino acids (Fig. 3).
Because the inhibitory effect of Dynasore was cancelled by
CHX, which increases cytoplasmic levels of amino acids, the
depletion of intracellular amino acids appears to be the main
mechanism of Dynasore-induced mTORC1 inactivation (Fig.
4). Moreover, the overexpression of Rheb or constitutively
active Rag rescued the decreased activity of mTORC1 observed
in Dynasore-treated cells (Fig. 5, A and B). In addition, consti-
tutively active Rag rescued the decreased lysosomal localization
of mTORC1 in Dynasore-treated cells (Fig. 5, C and D). These
findings suggest that Dynasore prevented amino acid-depen-
dent recruitment of mTORC1 to the lysosome by Rag and sub-
sequent activation of mTORC1 by Rheb.
Our findings presented here are consistent with a previous
study by Palm et al. (16), which suggested that in the presence of
extracellular amino acids, macropinocytosis inhibition does
not lead tomTORC1 inactivation. Therefore, in the presence of
extracellular amino acids, there should be a mechanism other
than macropinocytosis that effectively transports amino acids
to the lysosomal lumen. On the other hand, it has been shown
that cellular uptake of amino acids can be mediated by the
amino acid transporters on the plasma membrane (19). Amino
acids that enter the cytoplasm through the transporters will
readily activate cytoplasmic amino acid sensors (19) that
include Leucyl-tRNA synthetase (29), Sestrin2 (30), and CAS-
TOR (31). The existence of these cytoplasmic sensors may
explain why endocytosis inhibition has a milder effect than
amino acid starvation and the mTOR inhibitor Torin 1 (Fig. 2).
Nevertheless, our findings suggest that, in addition to the acti-
Figure 3. Amino acid-induced activation and lysosomal localization of mTORC1 is prevented by endocytosis inhibition. A, 293T cells were starved for
amino acids in amino acid-free RPMI1640 medium containing 10% dialyzed Nu-Serum in combination with 0.1% DMSO or 80 M Dynasore. After 50 min
starvation, cells were stimulated for 40 min with amino acids by adding 1/50 volume of50 amino acid solution containing L-glutamine. B, quantification of
immunoblot data in A. Mean values of two independent experiments are shown. C, 293T cells were treated as in A and subjected to immunofluorescencewith
anti-mTOR and anti-Lamp1 antibodies. Scale bar 10m.D, quantification of cells that exhibit lysosomal localization of mTOR by analysis of image data in C.
Each bar indicatesmean S.D. of three independent experiments. ***, p 0.001. E, quantification of fluorescence intensity ofmTOR on lysosomes by analysis
of image data in C. Each bar indicates mean S.D. of three independent experiments. ****, p 0.0001.
mTORC1 activation by amino acid endocytosis























vation of these cytoplasmic sensors, dynamin-dependent
endocytosis may play a critical role in the induction and
maintenance of mTORC1 activity by effectively transporting
extracellular amino acids to the lysosomal lumen.
The data shown here suggests that endocytosis inhibition
specifically inactivates mTORC1 and does not affect mTORC2
(Figs. 1 and 2), which is known to regulate multiple pathways
that include Akt-mediated pathways (4). In addition, the endo-
cytosis inhibitors used in this study differ frommTORC1 inhib-
itors (e.g. rapamycin) and amino acid starvation, both of which
are known to induce autophagy as a result of mTORC1 inhibi-
tion (3). In contrast to these conditions, the endocytosis inhib-
itors did not induce autophagy (Fig. 6). At first glance, it seemed
counterintuitive that endocytosis-inhibited cells exhibited
decreased autophagic activity even thoughmTORC1 was inac-
tivated. However, previous studies have shown that dynamin-
and clathrin-dependent endocytosis contribute to autophagy
progression (26, 27), whichmay explain the reduced autophagy
observed in endocytosis-inhibited cells.
In general, autophagy induced by starvation act as a compen-
satorymechanismby transporting a portion of the cytoplasm to
lysosomes (32). Cytoplasmic proteins are digested by lysosomal
hydrolases, which release amino acids that reactivatemTORC1
and other nutrients to support cell survival. This compensatory
autophagy was suppressed in endocytosis-inhibited cells (Fig.
6). Furthermore, it has been shown that mTORC1 inhibition
leads to enhanced lysosomal activity (33), and pharmacological
inhibition of mTORC1 induces accelerated digestion of
endocytosed proteins, thus supporting enhanced cell prolif-
eration in amino acid-deprived conditions (16). In contrast
to mTORC1 inhibitors, endocytosis inhibition suppresses
this compensatory amino acid generation via digestion of
endocytosed proteins even though mTORC1 is inactivated
(supplemental Fig. S2). Therefore, endocytosis inhibition
will result in a more thorough and sustained starvation of
amino acids and other nutrients because it suppresses the
utilization of extracellular nutrients and autophagy-depen-
dent nutrient generation.
Figure 4. Lysosomal localization and activation ofmTORC1 are preventedby endocytosis inhibition and rescuedbyCHX.A, 293T cells were treated for
1 h with 0.2% DMSO, 80 M Dynasore, or 80 M Dynasore and 10 g/ml of CHX, fixed, and stained with anti-mTOR and anti-Lamp1 antibodies. The results
shown are representative of three independent experiments. Scale bar  10 m. B, quantification of cells that exhibit lysosomal localization of mTOR by
analysis of image data in A. Each bar indicatesmean S.D. of three independent experiments. **, p 0.01. C, quantification of fluorescence intensity ofmTOR
on lysosomes by analysis of image data in A. Each bar indicates mean S.D. of three independent experiments. *, p 0.05; **, p 0.01. D, 293T cells were
treated for 1 or 4hwith 0.2%DMSO, 10g/ml of CHX, 80MDynasore, or 80MDynasore and10g/ml of CHX. E,quantificationof immunoblot data inD. Each
bar indicates mean S.D. of four independent experiments. *, p 0.05; **, p 0.01 compared with the vehicle treatment group.
mTORC1 activation by amino acid endocytosis























Because the suppression of mTORC1 is proposed to be a
potential therapeutic method for preventing cancer (4, 34), our
findings suggest that inhibition of endocytosismay be a reason-
able approach for the treatment of cancer. Cancer cells must
achieve sufficient energy production and biosynthesis to sup-
port their uncontrolled proliferation state (35). Consistently,
cancer cells exhibit increased uptake of amino acids and glu-
cose from the extracellular space compared with normal cells
(36–38). In addition to cancer, mTORC1 has also been linked
to aging because inhibition ofmTORC1by rapamycin increases
the life span in yeasts, worms, flies, and mice (39). Aging is
delayed by dietary restriction in many animal species (40), and
mTORC1 suppression appears to be a critical factor to explain
that phenomenon (39). Moderate endocytosis inhibition may
provide a method for nutrient restriction at the cellular level.
In summary, this study revealed the mechanism by which
endocytosis inhibition leads to mTORC1 inhibition effectively
and sustainably. Dynamin-dependent endocytosis is required
for the induction and maintenance of mTORC1 activity
through the constitutive transport of extracellular amino acids
to the lysosomal lumen. Finally, this study highlights dynamin-
dependent endocytosis as a novel target for cancer and aging.
Figure 5. DecreasedmTORC1 activity in endocytosis-inhibited cells is rescued by overexpression of Rheb and constitutively active Rag. A, 293T cells
were transfected with pRK5/HA-GST (mock); pRK5/HA-GST-RagB(99L) and pRK5/HA-GST(75L) (RagBGTP/RagCGDP); or pRK5/HA-GST-Rheb1 (Rheb). At 24 h
post-transfection, cells were treated for 4 hwith 0.1%DMSO (vehicle) or 80MDynasore. B,quantification of immunoblot data inA. Each bar indicatesmean
S.D. of three independent experiments. **, p 0.01. C, 293T cells were transfected as in A and subjected to immunofluorescence with anti-mTOR and anti-HA
antibodies.Arrows indicate colocalizationofmTORandRagB/C. Scale bar10m.D,quantificationof cells that exhibit punctatemTOR localizationby analysis
of image data in C. Only transfected (HA-positive) cells were examined. Each bar indicates mean S.D. of three independent experiments. ****, p 0.0001.
mTORC1 activation by amino acid endocytosis

























The following antibodies and reagents were used in this
study. Rabbit anti-phospho-Akt (Thr308) (number 13038), rab-
bit anti-phospho-Akt (Ser473) (number 4060), rabbit anti-phos-
pho-p70 S6 kinase (Thr389) (number 9234), rabbit anti-Akt
(number 4691), rabbit anti-Dynamin I/II (number 2342), rabbit
anti-GAPDH (number 5174), rabbit anti-mTOR (number
2983), rabbit anti-p70 S6 kinase (number 2708), and rabbit anti-
Raptor (number 2280) were from Cell Signaling Technology.
Rabbit anti-LC3 (PM036) was from MBL. Mouse anti-WIPI2
was fromMerckMillipore (clone 2A2).Mouse anti-HA tag was
from Covance (clone 16B12). Mouse anti-Lamp1 (sc-20011)
was from Santa Cruz Biotechnology. Goat anti-rabbit IgG
(HL)-HRP was from Jackson ImmunoResearch. Goat anti-
rabbit IgG (HL)-Alexa 488 and goat anti-mouse IgG (HL)-
Alexa 568 were from Thermo Fisher. Cellmatrix type I-C was
fromNitta Gelatin. DMEM, RPMI1640, CHX, and L-glutamine
solution were from Wako. Amino acid-free RPMI1640 was
from United States Biological. Dynasore and PitStop 2 were
from Abcam. Torin 1 was from Tocris Bioscience. Bafilomycin
A1 was from Adipogen. Nu-Serum growth medium supple-
ment, Lipofectamine 2000, and DQTM Red-BSA were from
Thermo Fisher. Cell counting kit-8: rabbit from Dojindo. Pro-
tease inhibitor mixture cOmplete and50 amino acid solution
for RPMI1640 were from Sigma.
Cells
HEK293T (293T) cells were obtained from RIKEN, and
maintained with DMEM containing 10% fetal bovine serum
(FBS) and 1 streptomycin/penicillin in a CO2 incubator con-
taining 5% CO2.
Immunoblotting
The 293T cells were plated in 12-well plates coated with col-
lagen (Cellmatrix type I-C) at a density of 2 105 cells/well in
RPMI1640 containing 10% Nu-Serum. Nu-Serum was used
instead of FBS because Dynasore is inhibited by albumin (41).
After incubation in a CO2 incubator for 18–21 h, cells were
treated as indicated in the figure legends. After incubating for
the indicated time length, cells were washed with phosphate-
buffered saline (PBS), lysed with cold lysis buffer (20 mM Tris-
HCl (pH 7.5), 150 mMNaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM
pyrophosphate, 1 mM -glycerophosphate, 1 mM orthovana-
date, 1% Triton X-100, and a protease inhibitor mixture
(cOmplete)), centrifuged at 14,000 rpm for 10 min at 4 °C, and
then the supernatants were mixed with sample buffer and
boiled for 5min. Samples were subjected to SDS-PAGEwith 10
or 15% acrylamide gels and transferred to PVDF membranes.
Membranes were treated with blocking buffer (Tris-buffered
saline containing 0.1%Tween 20 and 2% skimmilk). Proteins of
interest were detected with specific primary and secondary
antibodies using EzWestLumi plus (Atto) as the substrate.
Images were taken with LAS 3000 luminescent imager
(Fujifilm) or LuminoGraph I (Atto). The protein bands were
quantified by CSAnalyzer4 software (version 2.2.4, Atto).
Plasmid transfection
The 293T cells were plated in 12-well plates coated with col-
lagen at a density of 1 105 cells/well in RPMI1640 containing
10%Nu-Serum. After incubation in a CO2 incubator for 18–21
h, cells were transfectedwith 1g of pcDNA3.1/HA-dynamin 2
K44A (a gift from Sandra Schmid, Addgene plasmid number
34685), 1 g of pcDNA3.1() (Thermo Fisher Scientific), 0.25
g of pRK5/HA-GST-RagB(99L) (Addgene plasmid number
19303), 0.25 g of pRK5/HA-GST-RagC(75L) (Addgene plas-
mid number 19303), 0.5 g of pRK5/HA-GST-Rheb1 (Add-
gene plasmid number 19310) (the RagB, RagC, and Rheb1 plas-
mids are gifts fromDavid Sabatini), or 0.5g of pRK5/HA-GST
(a stop codon was inserted at the end of GST of pRK5/HA-
GST-Rheb1). Plasmid transfection was performed with Lipo-
fectamine 2000 following the manufacturer’s protocol.
Immunostaining
The 293T cells were plated onto coverslips coated with col-
lagen (Cellmatrix Type I-C) in 6-well plates at a density of 3
105 cells/well or in 12-well plates at 1  105 cells/well in
Figure 6. Endocytosis inhibition leads to decreased autophagic activity
even withmTORC1 inactivation. A, left: 293T cells were treated for 4 h with
DMSO, 80 M Dynasore, 30 M PitStop 2, 250 nM Torin 1, and 100 nM bafilo-
mycinA1 singly or in combination. All combinations contained0.175%DMSO
as solvent. Right: DMSO, 80M Dynasore, 30M PitStop 2, and 100 nM bafilo-
mycinA1were added singly or in combination toRPMI1640mediumcontain-
ing 10% Nu-Serum or to amino acid-free RPMI1640 medium containing 10%
dialyzed Nu-Serum, and 293T cells were treated with the indicated medium
for 4 h. All combinations contained 0.15%DMSOas solvent. B, 293T cellswere
treated as in A and subjected to immunofluorescencewith anti-LC3 and anti-
WIPI2 antibodies. Arrows indicate WIPI2 dots. Scale bar 10 m. C, quantifi-
cation of immunofluorescence data in B. Each bar indicates mean  S.D. of
three independent experiments. *, p 0.05; **, p 0.01; ****, p 0.0001.
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RPMI1640 containing 10% Nu-Serum. After incubation for
18–21 h in a CO2 incubator, cells were treated as indicated in
the figure legends. Cells were washed with PBS, and fixed with
4% paraformaldehyde in PBS for 20 min at room temperature.
Cells were then permeabilized with 0.05% Triton X-100 in PBS
(for mTOR/Lamp1 staining) or with 50 g/ml of digitonin (for
LC3/WIPI2 staining) for 5 min at room temperature, blocked
with 0.2% gelatin in PBS for longer than 30 min at room tem-
perature, and then subjected to immunostaining with specific
primary and secondary antibodies. Coverslips were mounted
with Prolong Gold with DAPI (Thermo Fisher), and images
were taken with the LSM 710 confocal microscope equipped
with an Alpha Plan-Apo100/1.46 NA objective lens (Zeiss).
Quantification ofmTOR-Lamp1 colocalization
Images of mTOR/Lamp1/DAPI immunostaining were ran-
domly taken by finding cells under a microscope by observing
only DAPI. Total cells, and cells that exhibit colocalization of
mTOR and Lamp1, were counted by an observer blinded to the
experimental condition. In addition, the same imageswere ana-
lyzed with Fiji/ImageJ software to quantify fluorescence inten-
sity of mTOR colocalized with the lysosomes as follows. First,
binary mask images for the cytoplasm, lysosomes, and nuclei
were created from the mTOR, Lamp1, and DAPI images. Next,
using themask images, the originalmTOR imagewas separated
into cytoplasmic and lysosomal areas (nuclear area was elimi-
nated from both areas). After calculating the average density of
mTOR in the cytoplasmic or lysosomal areas by dividing the
total fluorescence intensity of mTOR by the total pixels in the
area, the amount of mTOR on the lysosomes was calculated by
subtracting the cytoplasmic background from lysosomal
mTOR ([mTOR density in the lysosomes] [mTOR density in
the cytoplasm]). At least 30 cells were analyzed for each sample.
Quantification of cells withmTOR dots in RagBGTP/
RagCGDP-transfected cells
Images of mTOR/HA/DAPI immunostaining were exam-
ined to count cells with punctate patterns of mTOR. Only
transfected (HA-positive) cells were counted, and at least 150
cells were analyzed for each sample.
DQBSA assay
The 293T cells were plated onto coverslips in 6-well plates as
described above (under “Immunostaining”). At 18–20 h after
plating, cells were pre-treated for 30 min with Dynasore, Pit-
Stop 2, CHX, Baf A1, or a combination of the drugs as indicated
in the figure legends. After the pretreatment, 1/100 volume of
the 1 mg/ml of DQ Red-BSA (final concentration 10 g/ml)
solution was added. Plates were incubated in a CO2 incubator
for 4 h, and then cells were fixed with 4% paraformaldehyde in
PBS for 20min at room temperature. Coverslips weremounted
with Prolong Gold with DAPI (Thermo Fisher), and images
were taken with LSM 710 confocal microscope (Zeiss).
LC3-II turnover assay
LC3 in the cytoplasm (LC3-I, higher molecular weight)
becomes covalently attached to autophagosome membranes
(LC3-II, lower molecular weight), and LC3 attached to the
inner autophagosome membrane will be degraded in lyso-
somes. Therefore, the lysosomal turnover of LC3-II ([LC3-II
amount with Baf A1] [LC3-II amount without Baf A1]) indi-
cates the amount of autophagic structures that have been trans-
ported to the lysosomes during the time window of the treat-
ment and was used as a readout of autophagic activity (42).
Statistical analyses
Statistical significance was analyzed using GraphPad Prism 7
(GraphPad Software) to run unpaired t tests (Figs. 1 and 5D)
and one-way analysis of variance followed by Dunnett’s test
(Fig. 2) or by Tukey’s test (Figs. 3, 4, 5B, and 6).
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